Skip to main content
SpringerLink
Log in

Perceived medication use challenges and coping strategies among medical outpatients in Nigeria

  • Research Article
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

Background The use of medicines is an action that involves a change in behaviour and it is a complex construct involving reciprocal interactions between social, environmental and cognitive factors. This is particularly true when a patient uses medicines for asymptomatic chronic conditions, requiring life-long use. Objective To identify patient-perceived medication use challenges, determine the coping strategies used and investigate the relationship between patient-perceived challenges and self-initiation of coping strategies. Setting A premier 900-bed tertiary/teaching hospital located in Ibadan, Nigeria. Method Ten pharmacists conducted cross-sectional medication use interviews for a random sample of 324 medical outpatients in 4 weeks (25th October–19th November 2006). Main outcome measure Patient-perceived challenges with prescribed medications, self-initiated coping strategies used and relationship between patient-perceived challenges and self-initiation of coping strategies Results Eighty-one percent (324) of the random sample of 400 patients consented and completed the interview. Of these, 50.3 % were males while 49.7 % were females with mean age (SD) of 51.5 (17.6) and 52.1 (17.4) years respectively. The most frequent diagnoses were hypertension (53 %) and type-2 diabetes + hypertension (14.5 %). Two hundred and twenty-four patients reported one or more perceived challenges. Of these, 43.8 % were 65 years or older and about half reported at least 3 challenges. The majority (95.6 %) of patients who reported perceived challenges initiated one or more coping strategies without the knowledge of their physicians or pharmacists. Of 100 patients who did not report any perceived challenge, 43 % admitted initiating strategies to maintain perceived “cure” of their medical conditions. Self-initiation and use of coping strategies was far more likely among patients who reported perceived challenges (OR: 28.4, 95 % CI 26.1–30.5). The number of coping strategies reported appeared strongly related to the number of perceived challenges (r = 0.91, p < 0.001). Conclusion Perceived challenges associated with the use of prescribed medications and self-initiation of coping strategies appeared considerable among medical outpatients at a major teaching hospital in Nigeria. The risk of unauthorised initiation and use of varieties of coping strategies without the knowledge of clinicians was very high among patients who reported at least one perceived challenge.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. World Health Organization. Non communicable diseases and mental health adherence to long term therapies project. Adherence to long-term therapies: evidence for action. Geneva: WHO; 2003. p. 110. 1SBN 92 4 154599 2.

  2. Mazzaglia G, Ambrosioni E, Alacqua M, Filippi A, Sessa E, Immordino V, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation. 2009;120:1598–605.

    Article  PubMed  CAS  Google Scholar 

  3. DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002;40:794–811.

    Article  PubMed  Google Scholar 

  4. Simpson SH, Eurich DT, Majumdar SR, Padual RS, Tsuyuki RT, Varney J, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;33:15–8.

    Article  Google Scholar 

  5. Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am J Hypertens. 2006;19(11):1190–6.

    Article  PubMed  Google Scholar 

  6. Osterberg L, Blaschke T. Adherence to medications. N Engl J Med. 2005;353:487–97.

    Article  PubMed  CAS  Google Scholar 

  7. Jokisalo E, Kumpusalo E, Enlund H, Halonen P, Takala J. Factors related to non-compliance with antihypertensive drug therapy. J Hum Hypertens. 2002;6:577–83.

    Article  Google Scholar 

  8. Grant RW, Devita NG, Singer DE, Meigs JB. Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care. 2003;26:1408–12.

    Article  PubMed  Google Scholar 

  9. Heisler M, Bouknight RR, Hayward RA, Smith DM, Kerr EA. The relative importance of physician communication, participatory decision making and patient understanding in diabetes self-management. J Gen Intern Med. 2002;17(4):243–52.

    Article  PubMed  Google Scholar 

  10. Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management of chronic disease in primary care. JAMA. 2002;228(19):2469–75.

    Article  Google Scholar 

  11. Elwyn G, Edwards A, Britten N. “Doing prescribing”: how doctors can be more effective. BMJ. 2003;11:864–7.

    Article  Google Scholar 

  12. Cox K, Stevenson F, Britten N, Dundar Y. A systematic review of communication between patients and health care professionals about medicine-taking and prescribing. London: GKT Concordance Unit, King’s College; 2002.

  13. Svensson S, Kjellgren KI, Ahlner J, Säljö R. Reasons for adherence with antihypertensive medication. Int J Cardiol. 2000;76:157–63.

    Article  PubMed  CAS  Google Scholar 

  14. Rost K, Carter W, Inui T. Introduction of information during the initial medical visit: consequences for patient follow-through with physician recommendations for medication. Soc Sci Med. 1989;28:315–21.

    Article  PubMed  CAS  Google Scholar 

  15. Dowell J, Hudson H. A qualitative study of medicine-taking behaviour in primary care. Fam Pract. 1997;14(5):369–75.

    Article  PubMed  CAS  Google Scholar 

  16. Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean? (Or it takes at least two to tango). Soc Sci Med. 1997;44:681–92.

    Article  PubMed  CAS  Google Scholar 

  17. Donovan JL, Blake DR. Patient non-compliance: deviance or reasoned decision-making? Soc Sci Med. 1992;34:507–13.

    Article  PubMed  CAS  Google Scholar 

  18. Pollock K, Grime J. Strategies for reducing the prescribing of proton pump inhibitors (PPIs): patient self regulation of treatment may be an under-exploited resource. Soc Sci Med. 2000;51:827–39.

    Article  Google Scholar 

  19. Wallenius SH, Vainio KK, Korhonen MJH, Hartzema AG, Enlund HK. Self-initiated modification of hypertension treatment in response to perceived problems. Ann Pharmacother. 1995;29:1213–7.

    PubMed  CAS  Google Scholar 

  20. Kehoe WA, Katz RC. Health behaviours and pharmacotherapy. Ann Pharmacother. 1998;32:1076–86.

    Article  PubMed  CAS  Google Scholar 

  21. Turk D, Salovey P, Litt M. Adherence: a cognitive-behavioural perspective. In: Gerber K, Nehemkis A, editors. Compliance: the dilemma of the chronically ill. New York: Springer Publishing Co.; 1986. p. 44–72. ISBN 0-. 8771-4208-4.

  22. Barber N, Parsons J, Clifford S, Darracott R, Horne R. Patients’ problems with new medication for chronic conditions. Qual Saf Health Care. 2004;13(3):172–5.

    Article  PubMed  CAS  Google Scholar 

  23. Britten N, Ukoumunne O, Boulton MG. Patients’ attitudes to medicines and expectations for prescriptions. Health Expect. 2002;5:256–69.

    Article  PubMed  Google Scholar 

  24. Bandura A. Social learning theory. Englewood Cliffs: Prentice Hall; 1977. ISBN 013815614X.

  25. Skinner BF. Are theories of learning necessary? Psychol Rev. 1950;57(4):193–216.

    Article  PubMed  CAS  Google Scholar 

  26. Skinner BF. Science and human behavior. New York: Macmillan; 1953. ISBN 0 02 929040 6.

  27. Enlund HK, Jokisalo E, Wallenius S, Korhonen M. Patient-perceived problems, compliance and the outcome of hypertension treatment. Pharm World Sci. 2001;23(2):60–4.

    Article  PubMed  CAS  Google Scholar 

  28. Ajayi IO, Olumide EA, Oyediran O. Patient satisfaction with the services provided at a general outpatient clinic, Ibadan, Oyo state, Nigeria. Afr J Med Med Sci. 2005;34:133–40.

    PubMed  CAS  Google Scholar 

  29. Yusuff KB, Obe B, Joseph YB. Adherence to anti-diabetic drug therapy and self management practices among type-2 diabetics in a Nigerian tertiary care setting. Pharm World Sci. 2008;30:876–83.

    Article  PubMed  Google Scholar 

  30. Ernst E. Prevalence of use of complementary/alternative medicine: a systematic review. Bull World Health Organ. 2000;78:252–7.

    PubMed  CAS  Google Scholar 

  31. Tietzie K. Clinical skills for pharmacists: a patient-focused approach. St Louis: Mosby-year book inc.; 1997. p. 39–40.

  32. Svarstad BL, Chewining BA, Sleath BL, Claesson C. The brief medication questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns. 1999;37(2):113–24.

    Article  PubMed  CAS  Google Scholar 

  33. Lenaghan E, Holland R, Brooks A. Home-based medication review in a high risk elderly population in primary care-the POLYMED randomised controlled trial. Age Ageing. 2007;36:292–7.

    Article  PubMed  Google Scholar 

  34. Ndom RJE, Makanjuola AB. Perceived stress factors among resident doctors in a Nigerian teaching hospital. West Afr J Med. 2004;23(3):78–81.

    Google Scholar 

  35. Schectman JM, Nadkarni MM, Voss JD. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care. 2002;25:1015–21.

    Article  PubMed  Google Scholar 

  36. Stockl KM, Le L, Zhang S, Harada AS. Clinical and economic outcomes associated with potentially inappropriate prescribing in the elderly. Am J Manag care. 2010;16(1):1–10.

    Google Scholar 

  37. Huston PG. Moderating benzodiazepine use in the elderly: curbing physicians prescribing practices. Can Fam Physician. 1992;38:2459–543.

    PubMed  CAS  Google Scholar 

  38. Hedenmalm K, Spigset O. Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole). Eur J Clin Pharmacol. 2002;58(4):265–74.

    Article  PubMed  CAS  Google Scholar 

  39. Moorman J. Dipyrone (metamizole) use in the United States: a legal tango. South Med J. 2006;9:916.

    Article  Google Scholar 

  40. Benjamin SB, Ishak KG, Zimmerman HJ, Grushka A. Phenylbutazone liver injury: a clinical-pathologic survey of 23 cases and review of the literature. Hepatology. 1981;1:255–63.

    Article  PubMed  CAS  Google Scholar 

  41. Chaplin S. Bone marrow depression due to mianserin, phenylbutazone, oxyphenbutazone and chloramphenicol. Adv Drug React Acute Poisoning Rev. 1986;12: 97–136.

  42. Morgan T, Anderson A. The effect of non-steroidal anti-inflammatory drugs on blood pressure in patients treated with different anti-hypertensive drugs. J Clin Hypertens. 2003;5(1):53–7.

    Article  CAS  Google Scholar 

  43. Polonia J. Interaction of anti-hypertensive drugs with anti-inflammatory drugs. Cardiology. 1997;88(3):47–51.

    Article  PubMed  CAS  Google Scholar 

  44. Catella-Lawson F, Relly MP, et al. Cyclooxgenase inhibitors and the anti-platelet effects of aspirin. N Engl J Med. 2001;345(25):1809–17.

    Article  PubMed  CAS  Google Scholar 

  45. Macdonald TM, Wei L. Effect of ibuprofen on cardioprotective effect of aspirin. Lancet. 2003;361(9537):573–4.

    Article  PubMed  CAS  Google Scholar 

  46. Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment. J Amer Med Assoc. 2002;288:2880–3.

    Article  Google Scholar 

  47. Jameson JP, VanNoord GR. Pharmacotherapy consultation on polypharmacy patients in ambulatory care. Ann Pharmacother. 2001;35:835–40.

    Article  PubMed  CAS  Google Scholar 

  48. Scarsi KK, Fotis MA, Noskin GA. Pharmacist participation in medical rounds reduces medication errors. Am J Health Syst Pharm. 2002;59:2089–92.

    PubMed  Google Scholar 

Download references

Acknowledgments

I acknowledge the guidance & support of Prof. Fola Tayo, Faculty of Pharmacy, University of Lagos, Lagos, Nigeria. I also thank Mrs. B. Alao and the Master of Pharmacy students (02/03 set) for their contributions toward the successful conduct of the study. I am indebted to Dr Roy Jobson of the Faculty of Pharmacy, Rhodes University, South Africa for his editorial assistance.

Funding

None.

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. Department of Pharmacy Practice, College of Clinical Pharmacy, King Faisal University, Al-Ahsa, 31982, Kingdom of Saudi Arabia

    Kazeem B. Yusuff

Authors
  1. Kazeem B. Yusuff
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kazeem B. Yusuff.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yusuff, K.B. Perceived medication use challenges and coping strategies among medical outpatients in Nigeria. Int J Clin Pharm 35, 65–71 (2013). https://doi.org/10.1007/s11096-012-9706-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-012-9706-3

Keywords

Search

Navigation